Recent clinical studies of ECT.
D000275:Adjustment Disorders / Q000628:therapy; D000368:Aged; D000771:Anesthesia, Intravenous; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use; D001007:Anxiety; D001285:Atropine / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy / Q000628:therapy*; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D007839:Functional Laterality; D006801:Humans; D006998:Hypochondriasis / Q000150:complications; D008569:Memory Disorders / Q000517:prevention & control; D008723:Methohexital; D011379:Prognosis; D012110:Reserpine / Q000009:adverse effects; D012121:Respiration, Artificial; D013390:Succinylcholine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D001285:Atropine; D012110:Reserpine; D008723:Methohexital; D013390:Succinylcholine